BridgeBio Oncology Therapeutics, Inc. (BBOT)
Nasdaq: BBOT · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2023
Who runs BridgeBio Oncology Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Beltran Pedro
President and CEO. First filing Aug 2025, latest Oct 5, 2026, 0 filings in all.
Officers reporting now
9
of 19 people with a filing in the last fifteen months
Directors reporting now
10
20 people on the record since 2024
Officerssales are open-market, Oct 23, 2025 to Oct 23, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Cobo Marc | Principal Accounting Officer | Apr 2026 | Oct 23, 2026 | none |
| Beltran Pedro | President and CEO | Aug 2025 | Oct 5, 2026 | none |
| Elmelech Idan | COO & Principal Financial Ofcr | Apr 2026 | Oct 5, 2026 | none |
| Ben Yong | Chief Med & Dev Officer | Aug 2025 | Oct 5, 2026 | none |
| Chen Bihua | CEO and Chairperson | Feb 2024 | Jul 6, 2026 | none |
| Mehra Uneek | Chief Financial Officer | Aug 2025 | May 5, 2026 | none |
| Wallace Eli M. | Chief Executive Officer | Aug 2025 | Jan 5, 2026 | none |
| Tripp Caleb | Chief Financial Officer | Feb 2024 | Aug 11, 2025 | none |
| Obradovic Nebojsa | Chief Legal Officer | Feb 2024 | Aug 11, 2025 | none |
Directorssales are open-market, Oct 23, 2025 to Oct 23, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bauer Jake | director | Aug 2025 | Jun 18, 2026 | none |
| Kelleher Raymond J. | director | Aug 2025 | Jun 18, 2026 | none |
| Kumar Neil | director | Aug 2025 | Jun 18, 2026 | none |
| Lebowitz Peter F | director | Mar 2026 | Jun 18, 2026 | none |
| Mccormick Frank | director | Aug 2025 | Jun 18, 2026 | none |
| Tipirneni Praveen P. | director | Aug 2025 | Jun 18, 2026 | none |
| Doig Michelle | director | Aug 2025 | Aug 18, 2025 | none |
| Holman Albert A III | director | Feb 2025 | Aug 11, 2025 | none |
| Mckenna Mark C. | director | Feb 2024 | Aug 11, 2025 | none |
| Schmid John P. | director | Feb 2024 | Aug 11, 2025 | none |
Owners of more than 10% of a classsales are open-market, Oct 23, 2025 to Oct 23, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bridgebio Pharma LLC | 10% owner | Aug 2025 | Oct 16, 2025 | none |
| Bridgebio Pharma, Inc. | 10% owner | Aug 2025 | Oct 16, 2025 | none |
Earlier names on the record1, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.